 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX  Get Free Report) saw unusually-high trading volume on Monday . Approximately 2,463,247 shares were traded during mid-day trading, an increase of 142...

Amylyx Pharmaceuticals (NASDAQ:AMLX) Sees Strong Trading Volume

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX  Get Free Report) shares hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $19.48 and last traded at $19.61...

Amylyx Pharmaceuticals (NASDAQ:AMLX) Sets New 1-Year Low at $19.48

Investors in Amylyx Pharmaceuticals Inc (AMLX) saw new options become available this week, for the October 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down...

First Week of October 20th Options Trading For Amylyx Pharmaceuticals (AMLX)

Investors in Amylyx Pharmaceuticals Inc (AMLX) saw new options become available this week, for the November 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down...

First Week of AMLX November 17th Options Trading

Alpha Wave Global LP increased its stake in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX  Free Report) by 13.3% in the first quarter, according to the company in its most recent Form 13F filing...

Alpha Wave Global LP Has $27.30 Million Stock Holdings in Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)

Investors in Amylyx Pharmaceuticals Inc (AMLX) saw new options begin trading this week, for the February 2024 expiration. One of the key inputs that goes into the price an option buyer is willing to...

First Week of AMLX February 2024 Options Trading

Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Galecto (GLTO Research Report), Amylyx Pharmaceuti... Theres a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Galecto (GLTO Research Report), Amylyx ...

Analysts Are Bullish on Top Healthcare Stocks: Galecto (GLTO), Amylyx Pharmaceuticals Inc (AMLX)

Brown Advisory Inc. reduced its position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX  Free Report) by 44.8% in the first quarter, HoldingsChannel reports. The firm owned 18,461 shares of the companys stock after selling 14,980 shares during the quarter. Brown Advisory Inc.&#...

Brown Advisory Inc. Sells 14,980 Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX)

Investors eyeing a purchase of Amylyx Pharmaceuticals Inc (AMLX) stock, but cautious about paying the going market price of 21.27/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January ...

Commit To Purchase Amylyx Pharmaceuticals At $17.50, Earn 20% Using Options

In a report released today, Graig Suvannavejh from Mizuho Securities maintained a Buy rating on Amylyx Pharmaceuticals Inc (AMLX Research Report)... In a report released today, Graig Suvannavejh from Mizuho Securities maintained a Buy rating on Amylyx Pharmaceuticals Inc (AMLX &#8211...

Mizuho Securities Remains a Buy on Amylyx Pharmaceuticals Inc (AMLX)

Amylyx Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in the provision of disease-modifying solutions for neurodegenerative diseases. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Watchers	1,459
52-Wk Low	$17.80
52-Wk High	$41.93

Market Cap	$1.26B
Volume (M)	976,985.00
52-Wk High	$41.93
52-Wk Low	$17.80

AMLX Amylyx Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals